Literature DB >> 15001781

A toll-like receptor that prevents infection by uropathogenic bacteria.

Dekai Zhang1, Guolong Zhang, Matthew S Hayden, Matthew B Greenblatt, Crystal Bussey, Richard A Flavell, Sankar Ghosh.   

Abstract

Toll-like receptors (TLRs) recognize molecular patterns displayed by microorganisms, and their subsequent activation leads to the transcription of appropriate host-defense genes. Here we report the cloning and characterization of a member of the mammalian TLR family, TLR11, that displays a distinct pattern of expression in macrophages and liver, kidney, and bladder epithelial cells. Cells expressing TLR11 fail to respond to known TLR ligands but instead respond specifically to uropathogenic bacteria. Mice lacking TLR11 are highly susceptible to infection of the kidneys by uropathogenic bacteria, indicating a potentially important role for TLR11 in preventing infection of internal organs of the urogenital system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001781     DOI: 10.1126/science.1094351

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  289 in total

1.  Pellino 2 is critical for Toll-like receptor/interleukin-1 receptor (TLR/IL-1R)-mediated post-transcriptional control.

Authors:  Tae Whan Kim; Minjia Yu; Hao Zhou; Wei Cui; Jianan Wang; Paul DiCorleto; Paul Fox; Hui Xiao; Xiaoxia Li
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  The critical role of IL-1 receptor-associated kinase 4-mediated NF-κB activation in modified low-density lipoprotein-induced inflammatory gene expression and atherosclerosis.

Authors:  Tae Whan Kim; Maria Febbraio; Peggy Robinet; Brandon Dugar; Diane Greene; Anna Cerny; Eicke Latz; Raymond Gilmour; Kirk Staschke; Guy Chisolm; Paul L Fox; Paul E DiCorleto; Jonathan D Smith; Xiaoxia Li
Journal:  J Immunol       Date:  2011-01-28       Impact factor: 5.422

3.  The dual functions of IL-1 receptor-associated kinase 2 in TLR9-mediated IFN and proinflammatory cytokine production.

Authors:  Youzhong Wan; Tae Whan Kim; Minjia Yu; Hao Zhou; Michifumi Yamashita; Zizhen Kang; Weiguo Yin; Jian-An Wang; James Thomas; Ganes C Sen; George R Stark; Xiaoxia Li
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

Review 4.  Innate sensing of viruses by toll-like receptors.

Authors:  Karl W Boehme; Teresa Compton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Authors:  Jörg Vollmer; Risini D Weeratna; Marion Jurk; Ulrike Samulowitz; Michael J McCluskie; Paul Payette; Heather L Davis; Christian Schetter; Arthur M Krieg
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

Review 6.  Toll-like receptors in rheumatoid arthritis joint destruction mediated by two distinct pathways.

Authors:  C Ospelt; D Kyburz; M Pierer; R Seibl; M Kurowska; O Distler; M Neidhart; U Muller-Ladner; T Pap; R E Gay; S Gay
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 7.  Regulation of B-cell responses by Toll-like receptors.

Authors:  Edward P Browne
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

8.  MTA1 coregulator regulates LPS response via MyD88-dependent signaling.

Authors:  Suresh B Pakala; Sirigiri Divijendra Natha Reddy; Tri M Bui-Nguyen; Siddharth S Rangparia; Anitha Bommana; Rakesh Kumar
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

Review 9.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

10.  The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.

Authors:  Katarzyna Bulek; Shadi Swaidani; Jinzhong Qin; Yi Lu; Muhammet F Gulen; Tomasz Herjan; Booki Min; Robert A Kastelein; Mark Aronica; Magdalena Kosz-Vnenchak; Xiaoxia Li
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.